Results 181 to 190 of about 1,055,250 (236)
Some of the next articles are maybe not open access.

Anticholinergic Drugs

Anesthesia & Analgesia, 1994
Premedication has been shown to affect both oxygen consumption (VO2) and energy expenditure (EE). The metabolic responses to anticholinergic drugs have not been studied. In this study the effects of anticholinergic drugs on VO2 and EE (calculated from the measured rates of VO2 and carbon dioxide production [VCO2]: EE [kcal/d] = 3.581 x VO2 [L/d] + 1 ...
O. A. KIRVEL??   +3 more
openaire   +1 more source

Systematic review of anticholinergic risk scales in older adults

open access: yesEuropean Journal of Clinical Pharmacology, 2013
Anticholinergic drugs are often involved in explicit criteria for inappropriate prescribing in older adults. Several scales were developed for screening of anticholinergic drugs and estimation of the anticholinergic burden.
Robert Vander Stichele, Majda Azermai
exaly   +2 more sources

Anticholinergic Drugs in Psychiatry

International Clinical Psychopharmacology, 1989
This paper summarizes the research evidence pertaining to the use of anticholinergic drugs in psychiatric practice. Indications for use, efficacy and unwanted effects are discussed. The questions of withdrawal, association with tardive dyskinesia and abuse of these drugs is also covered. Finally there are some general recommendations regarding clinical
openaire   +2 more sources

The Anticholinergic Drug Scale as a Measure of Drug‐Related Anticholinergic Burden: Associations With Serum Anticholinergic Activity

The Journal of Clinical Pharmacology, 2006
Anticholinergic Drug Scale (ADS) scores were previously associated with serum anticholinergic activity (SAA) in a pilot study. To replicate these results, the association between ADS scores and SAA was determined using simple linear regression in subjects from a study of delirium in 201 long‐term care facility residents who were not included in the ...
Ryan M, Carnahan   +4 more
openaire   +2 more sources

Anticholinergics/Antimuscarinic Drugs in Asthma

Current Allergy and Asthma Reports, 2014
Anticholinergic alkaloids have been used for thousands of years for the relief of bronchoconstriction and other respiratory symptoms, and their use in the treatment of chronic obstructive pulmonary disease is well established. Acetylcholine, acting through muscarinic receptor (M) receptor, modulates multiple physiologic functions pertinent to asthma ...
Xavier, Soler, Joe, Ramsdell
openaire   +2 more sources

Efficacy of anticholinergic drugs in asthma

Expert Review of Respiratory Medicine, 2012
Although bronchial hyperresponsiveness to cholinergic agents is a main feature of asthma, the role of anticholinergic drugs in chronic asthma management has been largely underestimated. Several single-dose studies comparing acute bronchodilation induced by ipratropium bromide with salbutamol have shown that salbutamol was more effective than ...
Federica, Novelli   +3 more
openaire   +2 more sources

Managing drugs with anticholinergic activity

Drug and Therapeutics Bulletin, 2023
Over the past two decades, considerable data have emerged on an association between drugs with anticholinergic activity and serious adverse effects in older people. Well-recognised anticholinergic adverse effects include dry mouth, blurred vision, constipation and urinary retention.
openaire   +2 more sources

Anticholinergic drugs in asthma therapy

Current Opinion in Pulmonary Medicine, 2017
Current guidelines recommend a stepwise approach for pharmacological therapy aimed to achieve and maintain asthma control. Despite these recommendations, at least 50% of patients continue to be uncontrolled with risk of asthma exacerbations that can often be serious and are associated with deterioration of quality of life. In recent years, the interest
D'Amato, Maria   +4 more
openaire   +3 more sources

Tardive dyskinesia and anticholinergic drugs

American Journal of Psychiatry, 1983
The evidence from the literature does not support the notion that psychotropic drugs with central anticholinergic properties (antiparkinsonian drugs, neuroleptics, antidepressants) constitute a risk factor in tardive dyskinesia. Antiparkinsonian drugs tend to produce reversible increases in the severity of dyskinetic movements and can be used as ...
G, Gardos, J O, Cole
openaire   +2 more sources

Behavioural Actions of Anticholinergic Drugs

1972
Publisher Summary In this chapter, the effects of eight anticholinergic drugs are studied on three aspects of rat behavior. These include spontaneous motor activity, open-field behavior, and avoidance conditioning in a shuttlebox. The peripheral and central anticholinergic activities of the eight drugs are also measured in terms of their potencies in
R W, Brimblecombe, D A, Buxton
openaire   +2 more sources

Home - About - Disclaimer - Privacy